
ProKidney Corp (PROK) vs. Its Peers: A Comparison
Additionally, the 36-month beta value for PROK is 1.57. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 0
Additionally, the 36-month beta value for PROK is 1.57. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 0
ProKidney Corp (NASDAQ: PROK)’s stock price has gone decline by -18.00 in comparison to its previous close of 1.08, however, the company has experienced a
The stock price of ProKidney Corp (NASDAQ: PROK) has surged by 21.49 when compared to previous closing price of 0.75, but the company has seen
In the past week, PROK stock has gone up by 22.03%, with a monthly decline of -23.24% and a quarterly plunge of -54.86%. The volatility
The stock of ProKidney Corp (PROK) has gone down by -38.45% for the week, with a -47.69% drop in the past month and a -71.77%
ProKidney Corp (NASDAQ: PROK)’s stock price has gone decline by -15.28 in comparison to its previous close of 0.84, however, the company has experienced a
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.